Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes mellitus, a disease with significant effects on the health and economy of Western societies, involves disturbances in both lipid and carbohydrate metabolism. In the insulin-resistant or diabetic state, the liver is unresponsive to the actions of insulin with regard to the suppression of glucose output but continues to produce large amounts of lipid, the latter mimicking the fed, insulin-replete condition. The disordered distribution of lipids contributes to the cardiovascular disease that is the greatest cause of mortality of type 2 diabetes mellitus. Yet the precise signal transduction pathways by which insulin regulates hepatic lipid synthesis and degradation remain largely unknown. Here we describe a mechanism by which insulin, through the intermediary protein kinase Akt2/protein kinase B (PKB)-beta, elicits the phosphorylation and inhibition of the transcriptional coactivator peroxisome proliferator-activated receptor-coactivator 1alpha (PGC-1alpha), a global regulator of hepatic metabolism during fasting. Phosphorylation prevents the recruitment of PGC-1alpha to the cognate promoters, impairing its ability to promote gluconeogenesis and fatty acid oxidation. These results define a mechanism by which insulin controls lipid catabolism in the liver and suggest a novel site for therapy in type 2 diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AKT is a negative regulator of PGC-1α (Figure 3B).”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [68]
In the citing paper
“AKT phosphorylates and inhibits PGC-1α in response to insulin in liver [68] and activation of AKT causes a reduction in PGC-1α levels in heart [69].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [68]
Citations
Cites
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Self-citation
Cited by
Items 301–400 of 497
Veeranki, S., & Tyagi, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16011252 · Cited by 27
Ebrahimi, R., Bahiraee, A., Niazpour, F., Emamgholipour, S., & Meshkani, R. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29299 · Cited by 27
“Akt‐dependent phosphorylation of peroxisome proliferator‐activated receptor (PPAR) coactivator‐1α (PGC‐1α) also reduces gluconeogenesis and fatty acid oxidation activities of PGC‐1α.(17) PGC‐1α also causes overexpression of glucose and lipid homeostasis genes possibly through interacting with a number of transcription…”
BackgroundPGC1α downregulation and glycolytic phenotype in thyroid cancer
Liu, C., Yang, P., Wang, T., Huang, S., Kuo, Y.-H., & Cheng, S. (2019) · Journal of Cancer · doi:10.7150/jca.30018 · Cited by 24
“Previous studies indicated that phosphorylation of PGC1α by AKT could attenuate PGC1α activity [7, 26].”
BackgroundZheng, T., Hao, X., Wang, Q., Chen, L., Jin, S., & Bian, F. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.10.039 · Cited by 23
Zhou, H., Yuan, D., Gao, W., Tian, J., Sun, H., Yu, S., Wang, J., & Sun, L. (2020) · IUBMB Life · doi:10.1002/iub.2289 · Cited by 22
“We noticed that among the hub genes Akt1 has been found to influence PGC-1a abundance or activity through posttranslational modification, Akt1 phosphorylate PGC-1a and promote its ubiquitination degradation.(56) Thus, Akt1 is probably responsible for the regulation of PGC-1α by HtrA2/Omi.”
BackgroundKobayashi, H., Matsubara, S., Yoshimoto, C., Shigetomi, H., & Imanaka, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031172 · Cited by 24
“During high energy availability, insulin downregulates PGC-1 α transcription via pathways like the PI3K–AKT–FOXO axis, reducing reliance on oxidative metabolism [50,51] (Figure 1, mitochondrial function).”
Sajan, M. P., Ivey, R. A., & Farese, R. V. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.011 · Cited by 23
“This paradox may be explained by Akt-dependent phosphorylation/inhibition of PGC-1α (46), and/or inhibition resulting from reduced availability of FoxO1 needed for direct binding and activation of PGC-1α (10); in either case, the inhibitory effects of insulin on PGC-1α activity would prevail over increases in PGC-1α e…”
BackgroundFine-tuned regulation of the PGC-1α gene transcription by different intracellular signaling pathways
Hong, T., Ning, J., Yang, X., Liu, H.-Y., Han, J., Liu, Z., & Cao, W. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00225.2010 · Cited by 23
Post‐translational regulation of PGC‐1α modulates fibrotic repair
Larson‐Casey, J. L., Gu, L., Davis, D., Cai, G., Ding, Q., He, C., & Carter, A. B. (2021) · The FASEB Journal · doi:10.1096/fj.202100339r · Cited by 24
Gehrke, N., Wörns, M., Huber, Y., Hess, M., Straub, B. K., Hövelmeyer, N., Waisman, A., Kim, Y. O., Schuppan, D., Galle, P. R., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.026 · Cited by 22
Gene program-specific regulation of PGC-1α activity
Schmidt, S. F., & Mandrup, S. (2011) · Genes & Development · doi:10.1101/gad.2076411 · Cited by 24
“Furthermore, PGC-1a activity is inhibited by insulin-induced phosphorylations by Akt and Cdc2-like kinase 2 (CLK2) (Li et al. 2007; Rodgers et al. 2010).”
BackgroundInfluentialAntifibrotic role of PGC-1α-siRNA against TGF-β1-induced renal interstitial fibrosis
Wang, J., Chen, C.-W., Tsai, M.-R., Liu, S., Hung, T.-J., Yu-Ju-Hung, Chang, W., Shi, M., Hsieh, P., & Yang, Y. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.06.016 · Cited by 23
Hepatic DNAJB9 Drives Anabolic Biasing to Reduce Steatosis and Obesity
Sun, F., Liao, Y., Qu, X., Xiao, X., Hou, S., Chen, Z., Huang, H., Li, P., & Fu, S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.043 · Cited by 23
Gaspar, R. C., Muñoz, V. R., Nakandakari, S. C. B. R., Vieira, R. F. L., da Conceição, L. R., de Oliveira, F., Crisol, B., da Silva, A. S. R., Cintra, D. E., de Moura, L. P., et al. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111021 · Cited by 20
The Akt isoforms, their unique functions and potential as anticancer therapeutic targets
Santi, S. A., Douglas, A. C., & Lee, H. (2010) · BioMolecular Concepts · doi:10.1515/bmc.2010.035 · Cited by 21
“Knockdown of Akt2 with isoform-specific siRNA resulted in initially a cell cycle arrest and an increase in the mitochondrial volume, probably by upregulating PGC-1a (peroxisome proliferator-activated receptor-coactivator 1a), a key regulator of mitochondrial biogenesis (Santi and Lee, unpublished data).”
BackgroundStahel, P., Kim, J. J., Cieslar, S. R. L., Warrington, J., Xiao, C., & Cant, J. P. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.12.012 · Cited by 25
“Akt-mediated phosphorylation of PGC-1α and FOXO1 leads to their exclusion from the nucleus, thereby decreasing gluconeogenic gene expression [31,32].”
BackgroundDapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling
Kuang, J.-R., Zhang, Z., Leng, W., Lei, X., & Liang, Z. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.028 · Cited by 20
Ji, L., Wu, S., Fu, D., Fang, S., Xie, G., Fan, Y., & Bao, J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114815 · Cited by 20
Wang, G., Xu, J., Ma, H., Mu, Y., Xu, W., Yan, N., Liu, W., Zheng, D., Huang, X., & Li, L. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106569 · Cited by 20
Kuo, Y.-C., Chen, I.-Y., Chang, S. C., Wu, S., Hung, T., Lee, P., Shimotohno, K., & Chang, M. (2013) · Liver International · doi:10.1111/liv.12389 · Cited by 20
“Previous studies demonstrated that PGC-1a and FoxO1 are phosphorylated by Akt under the control of insulin signalling, resulting in the suppression of gluconeogenesis (41, 42).”
BackgroundLi, S., Chen, X., Yu, L., Saltiel, A. R., & Lin, J. D. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1227 · Cited by 23
PGC-1α activation: a therapeutic target for type 2 diabetes?
Yuan, D., Xiao, D., Gao, Q., & Zeng, L. (2018) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-018-0622-y · Cited by 20
Deficiency of bone morphogenetic protein-3b induces metabolic syndrome and increases adipogenesis
Martí-Pàmies, Í., Thoonen, R., Seale, P., Vite, A., Caplan, A., Tamez, J., Graves, L., Han, W., Buys, E. S., Bloch, D. B., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00362.2019 · Cited by 21
Distinct roles of UVRAG and EGFR signaling in skeletal muscle homeostasis
Kim, M. J., Febbraro, D., Farkona, S., Gillmore, T., Son, J. E., Regeenes, R., Chang, H. H., Pollock‐Tahiri, E., Yang, J., Park, Y. J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101185 · Cited by 21
“(D) Relative expression of genes related to mitochondrial deregulation (Fgf21 and Gdf15), mitochondrial biogenesis (Tfb1m and Tfb2m), mitochondrial oxidative phosphorylation (Cycs and Ndufb5), and muscle function (Pgc1a and Glut4) from tibialis anterior of the 6-month-old male mice (n ¼ 5e7).”
BackgroundInfluentialDoelman, J., Cao, H., Purdie, N. G., Kim, J. J. M., Swanson, K. C., Osborne, V., Tey, J., Ali, A. S., Feng, Z. Z., Karrow, N. A., et al. (2012) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2012.06.002 · Cited by 20
“Simultaneously, falling insulin levels stabilize the PGC-1α protein and accelerate its entry into the nucleus (Li et al., 2007).”
BackgroundInfluentialIntegrin-Dependent Akt1 Activation Regulates PGC-1 Expression and Fatty Acid Oxidation
Beeson, C., Beeson, G. C., Buff, H., Eldridge, J. D., Zhang, A., Seth, A. K., Demcheva, M. V., Vournakis, J. N., & Muise‐Helmericks, R. C. (2012) · Journal of Vascular Research · doi:10.1159/000332326 · Cited by 25
Chen, Y., Liu, H., Wang, Y., Yang, S. C., Yu, M., Jiang, T.-F., & Lv, Z. (2019) · Food & Function · doi:10.1039/c9fo01444f · Cited by 20
Lysenko, E. A., Vepkhvadze, T. F., Lednev, E. M., Виноградова, О. Л., & Popov, D. V. (2016) · The Journal of Physiological Sciences · doi:10.1007/s12576-016-0506-8 · Cited by 19
“However, activation of the insulin signaling pathway could deactivate PGC-1a protein [23, 24] and theoretically suppress exercise-induced mitochondrial biogenesis.”
BackgroundYun, S., & Park, J. (2020) · Anticancer Research · doi:10.21873/anticanres.13995 · Cited by 18
Jun, H., Gettys, T. W., & Chang, J. S. (2012) · PPAR Research · doi:10.1155/2012/320454 · Cited by 20
“Hindawi Publishing Corporation PPAR Research Volume 2012, Article ID 320454, 7 pages doi:10.1155/2012/320454”
BackgroundInfluentialCutting Edge: TCR Signal Strength Regulates Acetyl-CoA Metabolism via AKT
Hawse, W. F., Cattley, R. T., & Wendell, S. G. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900749 · Cited by 18
“Other studies demonstrated that AKT phosphorylated metabolic regulators including PGC1a (3) and ACLY (12).”
BackgroundWang, Y., Zhang, J., Chu, X., Wang, M., Xin, Y., & Liu, S. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01662-6 · Cited by 17
García‐Carrizo, F., Nozhenko, Y., Palou, A., & Rodríguez, A. M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25109 · Cited by 19
Teng, C. T., Beames, B., Merrick, B. A., Martin, N. P., Romeo, C., & Jetten, A. M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.033 · Cited by 17
Ondracek, C. R., & McLachlan, A. (2011) · Journal of Virology · doi:10.1128/jvi.00832-11 · Cited by 18
Chang, J. S., Jun, H., & Park, M. (2016) · Physiological Reports · doi:10.14814/phy2.13013 · Cited by 19
Bettedi, L., Yan, A., Schuster, E. F., Alic, N., & Foukas, L. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-60210-3 · Cited by 19
Mitochondrial quality control in liver fibrosis: Epigenetic hallmarks and therapeutic strategies
Jia, L., Yang, Y., Sun, F., Tao, H., Lu, C., & Yang, J. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111035 · Cited by 16
Akhtar, S., Culver, S. A., & Siragy, H. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-90952-7 · Cited by 17
Li, J., Chen, C., Zhang, W., Bi, J., Yang, G., & Li, E. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13535 · Cited by 17
Rubinelli, L., Manzo, O. L., Jin, S., Gaudio, I. D., Bareja, R., Marino, A., Palikhe, S., Mauro, V. D., Bucci, M., Falcone, D. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56869-9 · Cited by 15
Metformin—mechanisms of its glycemia-reducing effect
Drewe, J., Foretz, M., & Krähenbühl, S. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100106 · Cited by 19
Factors Affecting Insulin-Regulated Hepatic Gene Expression
Guan, H.-P., & Chen, G. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00006-5 · Cited by 18
Wessels, B., van den Broek, N. M. A., Čiapaitė, J., Houten, S. M., Wanders, R. J. A., Nicolay, K., & Prompers, J. J. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00144.2015 · Cited by 16
“This can be 388 explained by a decreased biosynthesis in the liver (24, 26, 28, 37), but also by 389”
BackgroundQuiroga, C., Mancilla, G., Oyarzún, I., Tapia, A., Caballero, M., Gabrielli, L., Valladares-Ide, D., del Campo, A., Castro, P., & Verdejo, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00546 · Cited by 18
“prevents the recruitment of PGC-1α to its promoter regions in hepatocytes (41).”
BackgroundIqbal, J., Jiang, H., Wu, H., Li, L., Zhou, Y., Hu, N., Xiao, F., Wang, T., Xu, S., & Zhou, H. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.03.016 · Cited by 16
“In response to insulin, AKT2 phosphorylates the transcriptional coactivator, peroxisome proliferator-activated receptor-coactivator 1 a (PGC-1 a), and reduces the recruitment of homologous promoters, thereby lowering liver gluconeogenesis and lipid oxidation.(15) AKT2 deficiency in mice causes severe diabetes and lipo…”
BackgroundHepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1‐driven gluconeogenesis
Liu, N., Yang, X., Guo, J., Zhang, L., Huang, S., Chen, J., Huang, J., Chen, Y., Cui, T., Zheng, Y., et al. (2023) · EMBO Reports · doi:10.15252/embr.202256390 · Cited by 17
Molecular Mechanisms for Age-Associated Mitochondrial Deficiency in Skeletal Muscle
Wagatsuma, A., & Sakuma, K. (2012) · Journal of Aging Research · doi:10.1155/2012/768304 · Cited by 16
“Akt/PKB directly phosphorylates PGC-1α and prevents the recruitment of PGC-1α to the cognate promoters, impairing its ability to promote gluconeogenesis and fatty acid oxidation [154].”
BackgroundEvidence that a mitochondrial death spiral underlies antagonistic pleiotropy
Stern, M. (2017) · Aging Cell · doi:10.1111/acel.12579 · Cited by 19
“In addition, PGC-1a activity is inhibited by Akt-dependent phosphorylation (Li et al., 2007), which might link the observed increase in IIS during aging with attenuated mitochondrial biogenesis.”
BackgroundFOX01 Is the Headline Akt Regulating Hepatic Glucose Metabolism
Smith, G. C., & Turner, N. A. (2017) · Endocrinology · doi:10.1210/en.2017-00525 · Cited by 15
Mitonuclear Communication in Stem Cell Function
Peng, B., Wang, Y., & Zhang, H. (2024) · Cell Proliferation · doi:10.1111/cpr.13796 · Cited by 16
“Conversely, phosphorylation by AKT can inhibit PGC-1α activity by preventing its recruitment to target promoter regions [128].”
Botezelli, J. D., Overby, P., Lindo, L., Wang, S., Haïda, O., Lim, G. E., Templeman, N. M., Pauli, J. R., & Johnson, J. D. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00128.2020 · Cited by 18
Effects of chronic hyperinsulinemia on metabolic pathways and insulin signaling in the fetal liver
Rozance, P. J., Jones, A. K., Bourque, S. L., D’Alessandro, A., Hay, W. W., Brown, L. D., & Wesolowski, S. R. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2020 · Cited by 16
Kumar, A. P., & Puthussery, D. T. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102887 · Cited by 16
Melo, A. M., Bittencourt, P., Nakutis, F. S., Silva, A. P., Cursino, J., dos Santos, G. A., Ashino, N. G., Velloso, L. A., Torsoni, A. S., & Torsoni, M. A. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011105 · Cited by 18
Clking on PGC-1α to Inhibit Gluconeogenesis
Cantó, C., & Auwerx, J. H. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.12.003 · Cited by 14
“It is interesting to note that Akt can also inhibit PGC-1a through direct phosphorylation on Ser570 (Li et al., 2007), a residue located in the SR domain, the region that is also phosphorylated by Clk2.”
BackgroundInfluentialEffects of the Activation of Three Major Hepatic Akt Substrates on Glucose Metabolism in Male Mice
Sakai, G., Inoue, I., Suzuki, T., Sumita, T., Inukai, K., Katayama, S., Awata, T., Yamada, T., Asano, T., Katagiri, H., et al. (2017) · Endocrinology · doi:10.1210/en.2016-1969 · Cited by 13
“Activation of Akt reportedly suppresses hepatic gluconeogenesis via direct phosphorylation of substrates, including FoxO1 (5), PGC1a (4), and others (6–9).”
BackgroundProteomic analysis of effects by x-rays and heavy ion in HeLa cells
Bing, Z., Yang, G., Zhang, Y., Wang, F., Ye, C., Sun, J.-T., Zhou, G., & Yang, L. (2014) · Radiology and Oncology · doi:10.2478/raon-2013-0087 · Cited by 14
Mechanisms of skeletal muscle atrophy in type 2 diabetes mellitus
Yang, H. J., Wang, Y., Xu, Y., Jia, X., & Lu, F. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1607873 · Cited by 13
“Akt (protein kinase B, PKB), a pivotal node in insulin receptor substrate (IRS) signaling, coordinates cellular proliferation, survival, and metabolic homeostasis through phosphorylation-dependent regulation of downstream effectors (Viglietto et al., 2002; Bao et al., 2004; Li et al., 2007).”
Lee, Y. G., Song, M., Cho, H., Jin, J., Park, B., & Bae, E. J. (2022) · Nutrients · doi:10.3390/nu14193904 · Cited by 12
“In contrast, Akt-mediated phosphorylation of PGC-1α inhibits its activity [53].”
BackgroundSun, X., Zeng, C., Wang, F., Zhang, Z., Yang, F., Liu, Z., Li, K., & Zhang, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113402 · Cited by 13
“Studies have proposed that the activity and stability of PPARGC1A are subject to posttranslational phosphorylation modifications, and the phosphorylation of PPARGC1A at Ser571 can decrease PPARGC1A activity [49].”
BackgroundSangeetha, N., & Nalini, N. (2014) · Human & Experimental Toxicology · doi:10.1177/0960327114530741 · Cited by 12
“Elimination of GCC expression induces genomic instability in intestinal epithelial cells, increasing DNA double-strand breaks, loss of heterozygosity, and point mutations in genes central to tumorigenesis, including APC and -catenin.(24) Earlier reports from our laboratory also revealed the accumulation of -catenin in…”
BackgroundGong, L., Debruyne, P. R., Witek, M. E., Nielsen, K. C., Snook, A. E., Lin, J. E., Bombonati, A., Palazzo, J., Schulz, S., & Waldman, S. A. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2009.00131.x · Cited by 12
Ogden, S., Carys, K., Ahmed, I., Bruce, J. I. E., & Sharrocks, A. D. (2022) · Oncogene · doi:10.1038/s41388-022-02465-w · Cited by 12
“We also detected a lapatinib-induced decrease in PPARGC1A phosphorylation at S571 (an inhibitory phosphorylation event; 39), providing further activation potential.”
Li, J., Zhu, L., Zhang, Y., Chen, H., Miao, Y., Kang, H., Ren, H., Wan, M., Long, D., & Tang, W. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/6190254 · Cited by 11
The Molecular Basis of PPAR Function
Barak, Y., & Lee, C. (2010) · PPAR Research · doi:10.1155/2010/510530 · Cited by 15
Gugusheff, J., Sim, P., Kheng, A., Gentili, S., Al-Nussairawi, M., Brand-Miller, J. C., & Mühlhäusler, B. S. (2015) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174415007965 · Cited by 12
GCN5 acetyltransferase inhibits PGC1α-induced hepatitis B virus biosynthesis
Tian, X., Zhao, F., Cheng, Z., Zhou, M., Zhi, X., Li, J., & Hu, K. (2013) · Virologica Sinica · doi:10.1007/s12250-013-3344-3 · Cited by 10
Role of PKB/Akt in Liver Diseases
Zhuravleva, E., Tschopp, O., & Hemmings, B. A. (2009) · Springer eBooks · doi:10.1007/978-3-642-00150-5_16 · Cited by 11
Rodríguez, R., Lee, A. Y., Godoy-Lugo, J. A., Martinez, B., Ohsaki, H., Nakano, D., Parkes, D. G., Nishiyama, A., Vázquez‐Medina, J. P., & Ortiz, R. M. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00584.2020 · Cited by 9
Tremblay, P. G., Fortin, C. S., & Sirard, M. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00934-6 · Cited by 11
“Furthermore, AKT targets many metabolism-related factors such as FOXO1 and peroxisome proliferator-activated receptor coactivator 1α (PGC1α) which regulate gene expression to increase gluconeogenesis and fatty acid oxidation [67].”
BackgroundXu, L., Zhou, K., Huang, X., Chen, H., Dong, H., & Chen, Q. (2024) · BMC Genomics · doi:10.1186/s12864-024-10084-w · Cited by 10
Non-catalytic mechanisms of KMT5C regulating hepatic gluconeogenesis
Zhao, Q., Cui, X., Zhu, Q., Li, F., Bao, R., Shi, T., Liu, H., Lv, W., Xu, Y., Gao, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56696-y · Cited by 9
Straightforward synthesis of novel Akt inhibitors based on a glucose scaffold
Cipolla, L., Redaelli, C., Granucci, F., Zampella, G., Zaza, A., Chisci, R., & Nicotra, F. (2009) · Carbohydrate Research · doi:10.1016/j.carres.2009.12.013 · Cited by 10
Dynamic sensitivity and control analyses of metabolic insulin signalling pathways
Liu, E., & Yuan, J. (2009) · IET Systems Biology · doi:10.1049/iet-syb.2008.0178 · Cited by 10
Latorre‐Muro, P., Varona, L., Burgos, C., Carrodeguas, J. A., & López‐Buesa, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179988 · Cited by 12
PTEN Deletion in Adult Mice Induces Hypoinsulinemia With Concomitant Low Glucose Levels
Crespo‐Masip, M., Pérez-Gómez, A., Guzmán, C., Rayego‐Mateos, S., Doladé, N. G., García-Carrasco, A., Jover, R., & Valdivielso, J. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.850214 · Cited by 10
“In addition, it is known that AKT phosphorylates peroxisome proliferatoractivated receptor-gamma coactivator 1 alpha (PGC1a) mediating the transcriptional repression of G6PC and PEPCK genes, as well as other genes involved in fatty acid oxidation (16, 17).”
BackgroundMIRNA146a And Diabetes-Related Complications: A Review
Maratni, N. P. T., Saraswati, M. R., Dewi, N. N. A., & Suastika, K. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666221014095715 · Cited by 10
A comprehensive review on phytochemicals for fatty liver: are they potential adjuvants?
do Moinho, T. M., Matos, S. L., & Carvalho, C. R. D. O. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02170-3 · Cited by 9
Xiong, Y., Hai, C.-X., Fang, W., Lei, Y., Li, X., & Zhou, X. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00486-4 · Cited by 8
“The former-catalyzed phosphorylation of PGC-1α may lead to a more stable and active protein, whereas the latter result in the decrease of its stability and transcriptional activity [9, 10].”
BackgroundSelf-citationReciprocal regulation of insulin and plasma 5′-AMP in glucose homeostasis in mice
Xia, L., Wang, Z., Zhang, Y., Yang, X. Y., Zhan, Y., Cheng, R., Wang, S., & Zhang, J. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0501 · Cited by 8
Ngamjariyawat, A., Cen, J., Said, R., Nilsson, C. I., Idevall‐Hagren, O., & Welsh, N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1060675 · Cited by 7
JNK Signaling Pathways and Oncoviruses
Behboudi, E., Charostad, J., Nakhaie, M., Khajouei, A., & Ghelmani, Y. (2024) · Iranian Journal of Medical Microbiology · doi:10.30699/ijmm.18.3.148 · Cited by 8
Miao, L., Pan, W.-J., Lin, Y., Ge, X., Liu, B., Ren, M., & Zhou, Q. (2017) · Genes & Genomics · doi:10.1007/s13258-017-0593-9 · Cited by 7
“The activation of Pi3k and Akt affects a downstream protein network, including rapamycin complex 1 (Mtorc1), Foxo1, and Pgc-1α, which are critical in insulin signaling pathway, insulin resistance, glucose uptake regulation, glycogen synthesis, glycolysis, and gluconeogenesis (Lynch and Adams 2014; Accili and; Arden 20…”
BackgroundElucidating the Role of Lipid-Metabolism-Related Signal Transduction and Inhibitors in Skin Cancer
Kook, E., & Kim, D. (2024) · Metabolites · doi:10.3390/metabo14060309 · Cited by 7
Prasanth, M. I., Malar, D. S., Verma, K., Prasansuklab, A., & Tencomnao, T. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.117871 · Cited by 6
Mishra, P., Albensi, B. C., & Fernyhough, P. (2025) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2025.104008 · Cited by 6
“Other pathways involved in PGC-1 α regulation include p38 MAPK, which can phosphorylate and activate PGC-1 α in muscle cells (Akimoto et al., 2005), and Akt (Protein kinase B) which can inhibit PGC-1 α activity through direct phosphorylation at Ser570 (Li et al., 2007).”
Hepatic MicroRNA Expression by PGC-1α and PGC-1β in the Mouse
Piccinin, E., Arconzo, M., Graziano, G., Vacca, M., Peres, C., Bellafante, E., Villani, G., & Moschetta, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225735 · Cited by 6
“By contrast with the aforementioned kinases, insulin-dependent activation of AKT (Protein Kinase B) results in a more unstable PGC-1α protein, with a lower transcriptional activity [40].”
BackgroundRuscetti, M. A., & Wu, H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6828-8_4 · Cited by 8
“Conversely, stimulation of the PI3K/ AKT pathway blocks gluconeogenesis by preventing both FOXO and PGC1α activation [ 55 , 56 ].”
BackgroundUnraveling mitochondrial dysfunction in polycystic ovary syndrome: Pathophysiological insights
Li, C.-J., Lin, L., Lin, P.-H., Chen, Y.-C., Lin, P.-W., Wen, Z., & Tsui, K. (2025) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000001281 · Cited by 7
“69 Additionally, oxidative stress associated with mitochondrial dysfunction promotes lipid peroxidation and inflammation, further aggravating cardiovascular complications in PCOS.”
The Role of Telomeres in Liver Disease
Sunami, Y., von Figura, G., Kleger, A., Strnad, P., Hüser, N., & Hartmann, D. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00007-4 · Cited by 6
Treindl, F., Zabinsky, E., Kling, S., Schwarz, M., Braeuning, A., & Templin, M. F. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02680-y · Cited by 5
“Interaction of PGC-1α and HNF4α is required for the expression of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (Li et al. 2007), the rate limiting enzymes of gluconeogenesis (Rhee et al.”
BackgroundHypoxia in skeletal muscles: from physiology to gene expression
(2016) · Musculoskeletal Regeneration · doi:10.14800/mr.1193 · Cited by 6
“Insulin signaling is found to inhibit PGC-1α activity through Akt [107] .”
BackgroundGöttig, L., & Schreiner, S. (2024) · Tumour Virus Research · doi:10.1016/j.tvr.2024.200277 · Cited by 4
“…metabolism, Akt inhibits FoxO1 leading to gene expression for gluconeogenesis and fatty acid oxidation, represses GSK-3 for energy regulation [168 – 173], phosphorylates and activates glycolytic enzymes (HK2, PFKFB2), and promotes expression of the glucose transporters and glycolytic enzymes…”
BackgroundA Genome-Wide siRNA Screen to Identify Modulators of Insulin Sensitivity and Gluconeogenesis
Yang, R., Lacson, R., Castriota, G. A., Zhang, X. D., Liu, Y., Zhao, W., Einstein, M., Camargo, L. M., Qureshi, S. A., Wong, K. K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036384 · Cited by 4
Liu, X., Gao, S., Gao, H., Jiang, X., & Wei, Q. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000986 · Cited by 4
Tissue specificity of energy metabolism in mitochondria
Moreno‐Loshuertos, R., & Fernández‐Silva, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00001-2 · Cited by 6
SMILE Is an Insulin-Inducible Transcriptional Corepressor of Hepatic Gluconeogenic Gene Programs
Kim, M., & Ahn, Y. (2015) · Diabetes · doi:10.2337/dbi15-0022 · Cited by 4
“Previously, it was believed that insulin suppression of gluconeogenesis was largely mediated through PKB activity via direct phosphorylation and dephosphorylation mechanisms (4).”
BackgroundPharmacological Activation of Mitochondrial Biogenesis for the Treatment of Various Pathologies
Gibbs, W. S., Scholpa, N. E., Beeson, C., & Schnellmann, R. G. (2018) · Wiley eBooks · doi:10.1002/9781119329725.ch39 · Cited by 4
Lin, H.-D., Tsai, R., Wen, Y., & Liu, P. (2025) · Antioxidants · doi:10.3390/antiox14121434 · Cited by 3
“Since PGC-1 α activity is modulated by AMPK, p38 MAPK, and AKT phosphorylation [20,21].”
Metadata
- Authors
- Li, X., Monks, B., Ge, Q., & Birnbaum, M. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Cell Signaling Technology (United States) (US)
- Corresponding author
- Birnbaum, Morris J.
- Venue
- Nature
- Published
- 2007-06
- Volume
- 447
- Issue
- 7147
- Pages
- 1012-1016
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1982810858
- Cited by
- 487
- References
- 29
- Citations by year
- 2026: 6 · 2025: 19 · 2024: 25 · 2023: 19 · 2022: 16 · 2021: 26 · 2020: 33 · 2019: 21 · 2018: 27 · 2017: 24 · 2016: 15 · 2015: 24 · 2014: 26 · 2013: 24 · 2012: 32
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PGC-1α, insulin signaling, hepatic metabolism, type 2 diabetes, insulin resistance, gluconeogenesis, fatty acid oxidation, cardiovascular disease
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Chromatin, Diabetes Mellitus, Type 2, Gene Expression Regulation, Glucose, Liver, Phosphorylation, Phosphoserine, Transcription Factors, Trans-Activators, Down-Regulation, Cell Line, Tumor, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.